Targeted Therapy at the End of Life in Advanced Cancer Patients
Author:
Affiliation:
1. Department of Hematology-Oncology, National University Hospital, National University Health System, Singapore.
2. Department of Pharmacy, National University Hospital, National University Health System, Singapore.
Publisher
Mary Ann Liebert Inc
Subject
Anesthesiology and Pain Medicine,General Medicine,General Nursing
Link
http://www.liebertpub.com/doi/pdf/10.1089/jpm.2012.0050
Reference39 articles.
1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
3. Trends in the Aggressiveness of End-of-Life Cancer Care in the Universal Health Care System of Ontario, Canada
4. Targeted Therapy at the End of Life for Patients with Lung Cancer
5. What Is Targeted Therapy?
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aggressive anticancer treatment in the last 2 weeks of life;ESMO Open;2024-03
2. Decisions about treatment with targeted therapies in a palliative care unit: A case series;Palliative and Supportive Care;2022-08-22
3. Differences in ICU Outcomes According to the Type of Anticancer Drug in Lung Cancer Patients;Frontiers in Medicine;2022-02-14
4. Therapeutic Futility in Terminal Cancer Patients: A Retrospective and Observational Study;Cureus;2021-03-24
5. Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital;American Journal of Hospice and Palliative Medicine®;2019-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3